Navigation Links
Landmark study analyzes scientific productivity and impact of the top 100 PD investigators
Date:6/9/2011

Amsterdam, NL, June 9, 2011 IOS Press is pleased to announce the publication of a landmark study in which both traditional and innovative scientometric approaches have been employed to identify the top 100 Parkinson's disease (PD) investigators since 1985 and measure their scientific productivity as well as the impact of their contributions to the field. The article appears today in the inaugural issue of the Journal of Parkinson's Disease.

This milestone analysis has been conducted by Aaron A. Sorensen, a noted expert in the fields of scientometrics and bibliometrics and currently Clinical Research Industry Specialist at GE Healthcare, and David Weedon, a Publishing Consultant based in London, formerly Managing Director of Biology Reports Ltd. While the study employs traditional bibliometric techniques to rank investigators, the authors have utilized innovative metrics to complement traditional tools that do not always give a full picture of the impact of a researcher's work.

"The number of citations an article receives is widely accepted as a measure of its impact," commented Sorensen and Weedon. "There has not, however, been a broad analysis of the PD research literature to assess, in a comprehensive manner, the impact and productivity of the top investigators, which this study aims to provide. It is interesting to note that approximately half the names in the Top 20 for the last decade are names that did not appear in the Top 20 for the last 25 years."

The authors have compiled a list of the 100 most cited PD researchers since 1985. The top 20 researchers identified are:

  1. Lees, Andrew J, University College London
  2. Marsden, C David, University College London
  3. Agid, Yves, Piti - Salptrire University Hospital, Paris
  4. Lang, Anthony E, Toronto Western Research Institute
  5. Olanow, C Warren, Mount Sinai School of Medicine, New York, NY
  6. Brooks, David J, Imperial College London
  7. Jenner, Peter, King's College London
  8. Mizuno, Yoshikuni, Juntendo University School of Medicine, Tokyo
  9. Fahn, Stanley, Columbia University, New York, NY
  10. Benabid, Alim-Louis, Joseph Fourier University, Grenoble
  11. Goetz, Christopher G, Rush University Medical Center, Chicago, IL
  12. Quinn, Niall P, University College London
  13. Pollak, Pierre, Joseph Fourier University, Grenoble
  14. Hirsch, Etienne C, Piti - Salptrire University Hospital, Paris
  15. Koller, William C, University of North Carolina, Chapel Hill, NC
  16. Lozano, Andres M, University of Toronto
  17. Riederer, Peter, Universitt Wzburg
  18. Jankovic, Joseph, Baylor College of Medicine, Houston, TX
  19. Daniel, Susan E, University College London
  20. Tanner, Caroline M, The Parkinson's Institute, Sunnyvale, CA

In order to get a sense for how the PD "impact landscape" might have changed in the 21st century, a Top 100 of the last decade was determined. The analysis revealed the names of a considerable number of "rising stars", who have made significant contributions to the PD literature, often through molecular or genetic approaches. The Top 20 identified are:

  1. Lang, Anthony E, Toronto Western Research Institute
  2. Farrer, Matthew, Mayo Clinic, Jacksonville, FL
  3. Lees, Andrew J, University College London
  4. Olanow, C Warren, Mount Sinai School of Medicine, New York, NY
  5. Singleton, Andrew, National Institute of Aging NIH, Bethesda, MD
  6. Przedborski, Serge, Columbia University, New York, NY
  7. Wood, Nicholas W, University College London
  8. Pollak, Pierre, Joseph Fourier University, Grenoble
  9. Benabid, Alim-Louis, Joseph Fourier University, Grenoble
  10. Poewe, Werner, Innsbruck Medical University
  11. Jankovic, Joseph, Baylor College of Medicine, Houston, TX
  12. Fahn, Stanley, Columbia University, New York, NY
  13. Hardy, John, University College London
  14. Agid, Yves, Piti - Salptrire University Hospital, Paris
  15. Lozano, Andres M, University of Toronto
  16. Albanese, Alberto, Universita Cattolica del Sacro Cuore, Milan
  17. Goetz, Christopher G, Rush University Medical Center, Chicago, IL
  18. Dawson, Ted M, Johns Hopkins University, Baltimore, MD
  19. Cookson, Mark R, National Institute on Aging NIH, Bethesda, MD
  20. Maraganore, Demetrius M, Mayo Clinic Minnesota, Rochester, MN

In addition, newer bibliometric methods were used as a means to assess productivity and impact. Researchers were ranked using H-indices (a measure of an author's highly-cited body of work), and "broad impact" citations were introduced as a novel way of identifying those scientists whose PD work has a large "ripple effect" beyond the PD research community.

Parkinson's disease is the second most common neurodegenerative disorder, affecting 1𔃀% of the population over the age of 65. It is characterized by loss of brain cells (neurons) from the mid-brain which use the neurotransmitter dopamine to help control voluntary movements.


'/>"/>

Contact: Daphne Watrin
d.watrin@iospress.nl
31-206-883-355
IOS Press
Source:Eurekalert

Related medicine news :

1. Support for Massachusetts landmark health reform law rises in 2011
2. UT Southwestern pediatricians launch landmark childrens health study
3. Stephen J. Teach, MD, MPH, part of landmark study on pediatric asthma
4. Feeling included -- kids with disabilities have their say in landmark study
5. Landmark report reveals massive global cost of Alzheimers: 1 percent of global GDP -- and growing
6. Landmark Clinical Trial Shows Surgery and Stenting Equally Safe and Effective at Preventing Stroke
7. Endometriosis Foundation of America to Present Landmark Scientific Symposium in NYC
8. China's Forbidden City Leads Landmark Climate Action for Earth Hour
9. Landmark Legal Foundation to File Suit to Stop Presidents Health Plan if Slaughter Rule is Used
10. Foodborne Illness Costs U.S. $152 Billion Annually, Landmark Report Estimates
11. California to Examine Health Impacts of Landmark Cap-and-Trade Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology: